SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by LHM Inc.

LHM Inc. boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 29.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 123,988 shares of the exchange traded fund’s stock after purchasing an additional 28,226 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 3.6% of LHM Inc.’s holdings, making the stock its 5th biggest position. LHM Inc. owned 0.16% of SPDR S&P Biotech ETF worth $11,166,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of XBI. Golden State Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at $29,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $29,000. Avior Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares in the last quarter. Tidemark LLC raised its stake in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares in the last quarter. Finally, Bank of Jackson Hole Trust acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $43,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $87.82 on Thursday. The firm has a fifty day moving average of $90.68 and a 200-day moving average of $95.52. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The stock has a market cap of $5.79 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.